Share-based Payment Arrangement, Expense in USD of Celularity Inc from Q3 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Celularity Inc quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q3 2020 to Q3 2025.
  • Celularity Inc Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2.04M, a 23.6% decline year-over-year.
  • Celularity Inc Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $10.1M, a 17.5% decline year-over-year.
  • Celularity Inc annual Share-based Payment Arrangement, Expense for 2024 was $11.6M, a 23% decline from 2023.
  • Celularity Inc annual Share-based Payment Arrangement, Expense for 2023 was $15M, a 5.29% decline from 2022.
  • Celularity Inc annual Share-based Payment Arrangement, Expense for 2022 was $15.9M, a 60.4% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Celularity Inc Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $10.1M $2.04M -$631K -23.6% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $10.7M $2.45M -$542K -18.1% 01 Apr 2025 30 Jun 2025 10-Q 29 Aug 2025
Q1 2025 $11.2M $2.64M -$329K -11.1% 01 Jan 2025 31 Mar 2025 10-Q 29 Aug 2025
Q4 2024 $11.6M $2.94M -$634K -17.7% 01 Oct 2024 31 Dec 2024 10-K 08 May 2025
Q3 2024 $12.2M $2.67M -$926K -25.7% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 $13.1M $2.99M -$866K -22.5% 01 Apr 2024 30 Jun 2024 10-Q 29 Aug 2025
Q1 2024 $14M $2.97M -$1.02M -25.6% 01 Jan 2024 31 Mar 2024 10-Q 29 Aug 2025
Q4 2023 $15M $3.58M -$811K -18.5% 01 Oct 2023 31 Dec 2023 10-K 08 May 2025
Q3 2023 $15.8M $3.6M -$921K -20.4% 01 Jul 2023 30 Sep 2023 10-Q 06 Dec 2024
Q2 2023 $16.7M $3.86M -$673K -14.9% 01 Apr 2023 30 Jun 2023 10-Q 07 Nov 2024
Q1 2023 $17.4M $3.99M +$1.57M +64.7% 01 Jan 2023 31 Mar 2023 10-Q 16 Oct 2024
Q4 2022 $15.9M $4.39M -$13.7M -75.8% 01 Oct 2022 31 Dec 2022 10-K 30 Jul 2024
Q3 2022 $29.6M $4.52M -$2.67M -37.1% 01 Jul 2022 30 Sep 2022 10-Q 03 Jan 2024
Q2 2022 $32.2M $4.53M -$9.19M -67% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $41.4M $2.42M +$1.41M +140% 01 Jan 2022 31 Mar 2022 10-Q 22 May 2023
Q4 2021 $40M $18.1M 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 $7.19M +$6.1M +564% 01 Jul 2021 30 Sep 2021 10-K 31 Mar 2023
Q2 2021 $13.7M 01 Apr 2021 30 Jun 2021 10-K 31 Mar 2023
Q1 2021 $1.01M 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q3 2020 $1.08M 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021

Celularity Inc Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $11.6M -$3.45M -23% 01 Jan 2024 31 Dec 2024 10-K 08 May 2025
2023 $15M -$839K -5.29% 01 Jan 2023 31 Dec 2023 10-K 08 May 2025
2022 $15.9M -$24.2M -60.4% 01 Jan 2022 31 Dec 2022 10-K 30 Jul 2024
2021 $40M +$35.6M +815% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 $4.37M 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.